- \n
- \nGE HealthCare and Mayo Clinic launch GEMINI-RT, a strategic initiative to personalize radiation therapy by integrating imaging, AI, and patient monitoring across the cancer care continuum.\n<\/li>\n
- \nThe collaboration focuses on four pillars, automation, predictive oncology, multi-modal therapies, and outpatient monitoring, with the aim to enhance clinical outcomes, reduce clinician burnout, and accelerate innovation in radiation oncology.\n<\/li>\n<\/ul>\n
CHICAGO–(BUSINESS WIRE<\/a>)–
\nGE HealthCare (Nasdaq: GEHC) and Mayo Clinic<\/a> today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023<\/a>, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology.\n<\/p>\n\nGEMINI-RT combines Mayo Clinic\u2019s world-class clinical and research expertise with GE HealthCare\u2019s leading technical and engineering innovation in oncology care and radiation therapy. The initiative aims to deliver comprehensive, personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey\u2014from detection and diagnosis to treatment and follow-up.\n<\/p>\n
\nRadiation therapy is a cornerstone of cancer care, used in more than 50% of cases worldwide and for over 2 million U.S. patients annually1,2<\/sup>. Rising global cancer incidence, 19.3 million new cases in 2022, continues to drive demand for this treatment3<\/sup>. Through GEMINI-RT, Mayo Clinic and GE HealthCare aim to make personalized radiation therapy accessible with new initiatives such as integrating streamlined, data-driven solutions, leveraging Mayo Clinic\u2019s clinical expertise and patient outcomes data.\n<\/p>\n
\n\u201cGEMINI-RT is grounded in the concept of \u2018twinning the patient, personalizing the beam\u2019\u2014a transformative approach made possible by Mayo Clinic\u2019s extensive clinical expertise and outcomes data,\u201d said Bryan Traughber, M.D., vice chair, innovation for radiation oncology, Mayo Clinic. \u201cThe combination of research and technological acumen could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to each patient.\u201d\n<\/p>\n
\nThe collaboration will deepen efforts across four strategic areas:\n<\/p>\n
- \n
- Automation: <\/b>Collaborating on AI-powered solutions that can eliminate repetitive tasks and accelerate treatment planning\n<\/li>\n
- Predictive Oncology: <\/b>Harnessing clinical insights to personalize cancer treatment decisions and improve outcomes.\n<\/li>\n
- Multi-modal Therapies: <\/b>Exploring approaches that combine radiation with emerging treatments like targeted drugs and precision heating for more effective care.\n<\/li>\n
- Connected Care<\/b>: Using AI, biomarkers, and sensors to monitor patients beyond the clinic\u2014with the aim to predict side effects early and support treatment at home.\n<\/li>\n<\/ul>\n
\n\u201cThis effort enables us to collaborate on solutions that are not only leading-edge but also clinically meaningful, helping shape the future of personalized radiation therapy. By integrating innovative technology and AI across the care continuum, we can improve clinician experience, support high-quality patient care, and help reduce burnout among care teams,\u201d said Dr. Ben Newton, Global Head of Oncology, GE Healthcare.\n<\/p>\n
\nGEMINI-RT Research and activities will be based at Mayo Clinic\u2019s campus in Rochester, Minnesota, leveraging both organizations\u2019 strengths in clinical practice, research, and product development. This research initiative builds on the 2023 strategic radiology research alliance in which GE HealthCare and Mayo Clinic are collaborating on projects in advanced Magnetic Resonance (MR) technologies and techniques, theranostics treatment for cancer, and diagnostic and interventional ultrasound.\n<\/p>\n
About Mayo Clinic<\/b><\/p>\n
Mayo Clinic<\/a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network<\/a> for additional Mayo Clinic news.\n<\/p>\n
About GE HealthCare Technologies Inc.<\/b><\/p>\n
\nGE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient\u2019s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.\n<\/p>\n
\nGE HealthCare is proud to be among 2025 Fortune World\u2019s Most Admired Companies\u2122<\/a>.\n<\/p>\n
\nFollow us on LinkedIn<\/a>, X<\/a>, Facebook<\/a>, Instagram<\/a>, and Insights<\/a> for the latest news, or visit our website https:\/\/www.gehealthcare.com<\/a> for more information.\n<\/p>\n
- Predictive Oncology: <\/b>Harnessing clinical insights to personalize cancer treatment decisions and improve outcomes.\n<\/li>\n
- Automation: <\/b>Collaborating on AI-powered solutions that can eliminate repetitive tasks and accelerate treatment planning\n<\/li>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20251203542689\/en\/1907724\/3\/GE_HealthCare_logo_NEW_March_2023.jpg\"){kind=logo}
<\/td>\n<\/tr>\n